All News

2021

April

Media Release / Apr 27, 2021

Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.

Read More

March

Media Release / Mar 05, 2021

Novartis announces change to the Executive Committee

Read More
Media Release / Mar 04, 2021

Novartis signs initial agreement with CureVac to manufacture COVID-19 vaccine candidate

Read More
Illustration of planet earth
Featured News / Mar 01, 2021

On a mission to transform planetary health

The first One Young World – Novartis Caucus took place virtually on February 11, 2021.

Read More

February

Media Release / Feb 08, 2021

Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukemia

Read More

January

Media Release / Jan 29, 2021

Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine

Read More
Media Release / Jan 29, 2021

Novartis renews WHO medicine donation pledge with aim of ending leprosy

Read More
Three engineers walking in the modern and bright lab
Featured News / Jan 26, 2021

Novartis 2020 Financial Results

Novartis announces the company’s fourth quarter and 2020 full year financial results.

Read More
Media Release / Jan 26, 2021

Novartis delivered sales growth and margin expansion. Continued to progress its next wave of medicines in 2020.

Read More
Media Release / Jan 19, 2021

Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.

Learn More